Sotyktu

deucravacitinib

Approval

ApplicationNDA 214958
Approval dateSep 9, 2022
Approval year2022
SponsorBristol

FDA-approved use

To treat moderate-to-severe plaque psoriasis

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Sotyktu: